Accessibility Menu
 
Cronos Group logo

Cronos Group

(NASDAQ) CRON

Current Price$2.59
Market Cap$959.00M
Since IPO (2016)+1,433%
5 Year-73%
1 Year+40%
1 Month-3%

Cronos Group Financials at a Glance

Market Cap

$959.00M

Revenue (TTM)

$193.36M

Net Income (TTM)

$9.45M

EPS (TTM)

$-0.02

P/E Ratio

-102.85

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$2.59

Volume

30,550

Open

$2.53

Previous Close

$2.53

Daily Range

$2.53 - $2.59

52-Week Range

$1.60 - $3.43

CRON: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cronos Group

Industry

Pharmaceuticals

Employees

610

CEO

Michael Ryan Gorenstein

Headquarters

Stayner, ON M5V 2H1, CA

CRON Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-10%

Net Income Margin

-6%

Return on Equity

-88%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-0.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$959.00M

Shares Outstanding

379.05M

Volume

30.55K

Short Interest

0.00%

Avg. Volume

1.23M

Financials (TTM)

Gross Profit

$62.76M

Operating Income

$2.93M

EBITDA

$15.00M

Operating Cash Flow

$26.32M

Capital Expenditure

$26.17M

Free Cash Flow

$151.61K

Cash & ST Invst.

$831.79M

Total Debt

$1.51M

Cronos Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$91.31M

+201.3%

Gross Profit

$16.19M

+49.8%

Gross Margin

17.73%

N/A

Market Cap

$959.00M

N/A

Market Cap/Employee

$2.09M

N/A

Employees

459

N/A

Net Income

$1.82M

-104.2%

EBITDA

$44.51M

-403.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$830.28M

-3.1%

Accounts Receivable

$57.20M

+92.1%

Inventory

$46.75M

+41.0%

Long Term Debt

$1.17M

+17.8%

Short Term Debt

$337.00K

-67.1%

Return on Assets

-0.79%

N/A

Return on Invested Capital

-1.31%

N/A

Free Cash Flow

$9.87M

+146.1%

Operating Cash Flow

$12.03M

+55.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCRXPacira BioSciences, Inc.
$22.52-0.79%
AMPHAmphastar Pharmaceuticals, Inc.
$20.64+0.94%
XNCRXencor, Inc.
$12.77-0.30%
PHATPhathom Pharmaceuticals, Inc.
$11.15-1.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.91-0.04%
FCUVFocus Universal
$6.55+0.96%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.38+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$76.72-0.01%

Questions About CRON

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.